AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its ...

There’s a profound difference between depriving yourself—believing certain foods are off-limits because they’re “bad”—and ...

About itepekimab Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug ... are "no anomalies […] that would cause the board to adopt an alternative view" of its prospects.

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically me ...

District residents will be able to vote on the budget, and school board candidates, on May 20. The proposal includes a tax levy of $36,803,460, an increase of 3.25% but under the state-imposed cap ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, June 1, 2025, the moon is 5 days old and is in the Waxing Crescent phase of its lunar ...

We are pleased to share the May 2025 issue of Wilson Sonsini’s Sustainability and ESG Advisory Practice Update. Each issue combines news, key ...

Q1 2025 highlighted the growing traction of the company's data collection solutions with leading AI and eCommerce players worldwide Company ...